Hearings to examine the TRICARE pharmacy program

Health Care Costs and Drug PricingSenate Armed Services Subcommittee on Personnel · 2026-07-15 · 119th Congress
The Senate Armed Services Subcommittee on Personnel held this hearing to examine the TRICARE pharmacy program, focusing on the Defense Health Agency's contract with Express Scripts/Evernorth and complaints that the arrangement lets a single vertically integrated company both manage and compete against the retail pharmacy network. Begins at 0:15:08
Transcript
Highlights

Title

Oversight of TRICARE's pharmacy contract and Express Scripts conflicts of interest

Purpose

The Senate Armed Services Subcommittee on Personnel held this hearing to examine the TRICARE pharmacy program, focusing on the Defense Health Agency's contract with Express Scripts/Evernorth and complaints that the arrangement lets a single vertically integrated company both manage and compete against the retail pharmacy network. Witnesses included a Defense Health Agency official, the president of Express Scripts and Evernorth Care Management, an independent New Mexico pharmacist forced out of the network, and a representative of the American Pharmacy Cooperative. Much of the questioning centered on pharmacy closures, spread pricing, and whether DOD should prohibit vertical integration in the next pharmacy contract. Begins at0:15:08

Who spoke

Chair Tuberville0:15:08: Opened by framing the hearing around beneficiary access to medications and readiness0:16:08, stressed that "savings on paper" that delay treatment aren't real savings0:16:29, and closed by likening the dispute to "a failure to communicate"1:47:09.

Sen. Warren, Ranking Member0:17:47: Said 13,000 pharmacies have left the TRICARE network since 2022, affecting 400,000 military families0:18:16; detailed Express Scripts' 23-year, $4.2 billion exclusive contract and argued it is required by DOD to own both a PBM and a pharmacy, creating a conflict of interest0:19:290:20:41; later pressed Dr. Kautzner on contract language and DOD pricing data0:55:301:31:38.

Dr. Smith, Defense Health Agency (Admiral)0:25:25: Testified the TRICARE contract uses a pharmacy benefit administrator model paid a fixed fee rather than drug-price revenue0:26:41, citing over $22 billion in cumulative savings and $2 billion projected for FY260:28:02, and a network of 46,000 pharmacies exceeding the contractual floor0:29:02; later acknowledged it would be "reasonable" to revisit vertical integration1:38:01.

Dr. Kautzner, President, Express Scripts and Evernorth Care Management0:30:59: Said the program serves more than 9 million beneficiaries with over 46,000 network pharmacies0:33:25 and cited GAO findings that this is one of only two major TRICARE contracts to decrease costs over time0:34:20; repeatedly declined to confirm the "100% pass-through" claim would hold up under an independent audit1:00:061:02:07.

Dr. Lansford, pharmacist, Roden-Smith Pharmacy (Clovis, NM)0:34:58: Said Express Scripts forced his pharmacy out of TRICARE in 2023 after reimbursement fell $.37 below drug cost, then would have dropped nearly $9 below cost per prescription under the new contract0:36:170:36:38; described losing the ability to serve a disabled retired airman and deployed military spouses0:37:310:37:50.

Mr. Reybold, American Pharmacy Cooperative0:39:41: Argued Express Scripts' TRICARE conduct is "the poster child" for barring PBMs from owning pharmacies0:40:10; said DHA's own data shows generic drugs average 85% cheaper at retail than mail-order0:41:32, and cited an OIG finding of an $18 million discrepancy between reported and actual reimbursements in other federal contracts0:43:51.

Sen. Scott0:45:02: Drew an analogy to buying fighter jets from China to question reliance on foreign-sourced drugs0:45:54; pressed Dr. Smith on how Express Scripts is paid and whether it profits from drug pricing0:47:40.

Sen. King1:07:19: Called the contract's logic "puzzling," asking why a company managing drug distribution is also in the drug distribution business1:08:49; pressed the analogy of the manager also owning CVS, calling the conflict "obvious"1:40:16.

Senator Smith1:15:35: Asked Dr. Smith about the unique value of mail-order pharmacy for a worldwide-deployed force1:16:02 and how DOD measures Express Scripts' performance, noting customer satisfaction rates in the 90s1:18:10.

Senator Blumenthal1:21:00: Asked whether manufacturer rebates influence Express Scripts' formulary role, and Dr. Kautzner said DHA makes all clinical and rebate decisions1:21:21; raised concerns about PBMs disrupting stable mental health medication regimens1:23:06.

Key moments

Sen. Warren said 13,000 pharmacies have left the TRICARE network since 2022, displacing 400,000 military families who must find new pharmacies0:18:16.

Warren highlighted contract Section 3.5, giving Express Scripts an "aggregate reimbursement reconciliation and offset methodology"; Reybold called it "the biggest smoking gun document I have seen in a hearing"0:55:300:57:20.

Dr. Lansford said he was reimbursed $.37 below drug cost in his last year in the network (2022), and would have lost nearly $9 per prescription under Express Scripts' revised rates0:36:170:36:38.

Reybold cited a federal Inspector General audit finding Express Scripts' reported drug prices to Federal Employee Health Plan clients didn't match the lower reimbursements it negotiated with pharmacies, by $18 million0:43:51.

Reybold said DHA data shows Express Scripts' mail-order pharmacy lost about 9% of utilization to retail pharmacies between 2018 and 2022, shortly before roughly 13,000 retail pharmacies were purged from the network0:42:000:42:30.

Warren cited DOD's own FY2023 reported data showing Express Scripts' mail-order generic fills cost 12.5% more on average than the same prescriptions filled at retail pharmacies1:31:38.

Warren presented an explanation-of-benefits showing mail-order pharmacies charge the full $14 co-pay even when a drug costs as little as $3, while retail pharmacies are bound by law to charge the "lesser of" the co-pay or actual cost1:33:301:34:24.

Sen. King and Warren pressed Dr. Smith on why the same contractor is allowed to both manage drug distribution and own a competing mail-order pharmacy; Dr. Smith conceded it was "reasonable for us to look at"1:08:491:38:01.

Warren pressed Dr. Kautzner five times on whether Express Scripts would support an independent audit to confirm full pass-through of savings; Kautzner never gave a direct yes, saying only the company would "comply with what Congress and DHA say we need to do"1:01:081:01:54.

Dr. Smith testified the government has recognized over $22 billion in cumulative pharmacy savings since the program began, with $2 billion projected for FY26, and $6.5 billion saved in FY25 through federal supply schedule pricing0:28:020:29:57.

Metadata

CommitteeSenate Armed Services Subcommittee on Personnel
Chamber / CongressSenate · 119th Congress
Date2026-07-15
TypeOpen Hearing
Witnesses
(none listed in event metadata)
Videosenate-isvp
Transcript248 caption blocks · 11,850 words · 1:48:05 runtime
EventCongress.gov 338612